FDA — authorised 1 April 1971
- Application: ANDA061449
- Marketing authorisation holder: APOTHECON
- Local brand name: STAPHCILLIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 METHICILLIN SODIUM in United States
FDA authorised METHICILLIN SODIUM on 1 April 1971
Marketing authorisations
FDA
- Status: approved
FDA
- Application: NDA050117
- Marketing authorisation holder: APOTHECON
- Local brand name: STAPHCILLIN
- Indication: INJECTABLE — INJECTION
- Status: approved
METHICILLIN SODIUM in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is METHICILLIN SODIUM approved in United States?
Yes. FDA authorised it on 1 April 1971; FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for METHICILLIN SODIUM in United States?
APOTHECON holds the US marketing authorisation.